Zacks Investment Research on MSN23h
Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits FailureThis week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of ...
The 31 March decision in Texas dismissed the Chapter 11 bankruptcy protection case of J&J subsidiary Red River Talc, which ...
Johnson & Johnson has signaled that it will attempt to disqualify certain plaintiffs' lawyers and use other aggressive ...
J&J revealed that its proposed prepackaged bankruptcy plan for Red River Talc LLC was not approved by the U.S. Bankruptcy Court for the Southern District of Texas. Instead of appealing, J&J plans to ...
The lemon, now black and shriveled, helped convict Karl Muller, a German spy in Britain during World War I. It was found by ...
The EV maker is slated to report first-quarter sales data Wednesday morning. Wall Street expects just under 380,000 vehicles. The number reported probably won't be that high.
A federal bankruptcy judge has rejected Johnson & Johnson’s latest attempt to settle lawsuits that allege its talc baby ...
The latest rejection looks set to mark the end of J&J's drive to resolve the litigation through the bankruptcy courts, as the ...
Bankruptcy judge rejects the healthcare-products company’s third attempt to resolve mass talc lawsuits through chapter 11.
A US bankruptcy judge has rejected Johnson & Johnson’s latest attempt to resolve tens of thousands of cancer claims through a ...
A judge dismissed an attempt to use a bankruptcy court to resolve tens of thousands of claims that the company’s talcum power ...
A federal judge has rejected Johnson & Johnson’s latest attempt to resolve lawsuits its talc products caused cancer, ruling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback